Ropes & Gray represented Sanofi Ventures in its role as co-lead investor in Diagonal Therapeutics’ $125 million Series B financing. Diagonal Therapeutics develops disease-modifying clustering antibodies intended to correct dysregulated signaling in severe genetic disorders.
The financing round was co-led by Sanofi Ventures and Janus Henderson Investors.
The Ropes & Gray team included venture capital and emerging companies associates Derek Mubiru and Kayla King, and venture capital and emerging companies partner Rajarshi Banerjee.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.